Literature DB >> 7666903

Hydroxyurea and sickle cell crisis.

R T Silver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7666903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Treatment of polycythemia vera with recombinant interferon.

Authors:  Richard T Silver
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  Bone marrow transplant for sickle cell disease--an update.

Authors:  S C Davies; I A Roberts
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

Review 3.  Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.

Authors:  Richard T Silver
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 4.213

4.  The influence of hydroxyurea on oxidative stress in sickle cell anemia.

Authors:  Lidiane de Souza Torres; Danilo Grünig Humberto da Silva; Edis Belini Junior; Eduardo Alves de Almeida; Clarisse Lopes de Castro Lobo; Rodolfo Delfini Cançado; Milton Artur Ruiz; Claudia Regina Bonini-Domingos
Journal:  Rev Bras Hematol Hemoter       Date:  2012

5.  Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatment.

Authors:  Fabia Neves; Osvaldo Alves Menezes Neto; Larissa Bueno Polis; Sarah Cristina Bassi; Denise Menezes Brunetta; Ana Cristina Silva-Pinto; Ivan Lucena Angulo
Journal:  Rev Bras Hematol Hemoter       Date:  2012

6.  Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia".

Authors:  Eduard Johannes van Beers; Gregory James Kato
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.